Venebio conducts comprehensive scientific review and evaluation of worldwide epidemiologic research to support informed decision-making for clients in pharmaceutical, biotechnology and other industries, as well as academic, legal, governmental and healthcare organizations.

Epidemiology focus areas include:

  • Systematic literature reviews and meta-analyses
  • Complex disease epidemiology
  • Pharmacoepidemiology
  • Clinical epidemiology
  • International, population health
  • Genetic, molecular, and environmental epidemiology
  • Scientific report writing, manuscript preparation and submission

Specialty therapeutic areas include:

  • Respiratory disease
  • CNS disease
  • Oncology
  • Psychiatry
  • Cardiovascular disease, obesity and diabetes
  • GI disease
  • Harm reduction
  • Pain addiction and drug abuse

Selected Publications:

Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Zedler, B.K., et al. Addiction. 2016. In press.

Comparison between cardiometabolic risk biomarkers in a clinical laboratory patient cohort and the U.S. adult population. Wolin, E., et al. Journal of Clinical Lipidology, 2016. Under review.

A genetic epidemiological mega study of smoking initiation in adolescents. Maes, H.H., et al. Journal of the American Medical Association. 2016. Under review.

Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans’ Health Administration patients. Zedler, B.K., et al. Pain Medicine. 2015.

Abuse and diversion of buprenorphine sublingual tablets and film. Lavonas, E.J., et al. Journal of Substance Abuse Treatment. 2014.

Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. Hawn, M.T., et al. JAMA Surgery. 2013.

Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. Lavonas, E.J., et al. Journal of Pediatrics. 2013.

A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Zedler, B.K., et al. Clinical Therapeutics. 2011.

Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Zedler, B.K., et al. Clinical Therapeutics. 2011.
 

What Our Clients Say:

Our organization has benefited across the pipeline from Venebio’s unique and visionary business model. Numerous times in years past, we have asked Venebio to leverage its growing global network of experts. With every new engagement, Venebio moves swiftly to put together a project-specific team, built around some of the world’s leading talent, whether in clinical trial design and analysis, personalized medicine, pharmacovigilance, pharmacoepidemiology or patent due diligence support, to provide consistently high-quality, on-time deliverables to our business.

Christian Heidbreder, PhD, Global Head of R&D, Indivior, Inc.